Latent
-41%
est. 2Y upside i
Medical language models to automate healthcare operations
Rank
#1269
Sector
Healthcare IT
Est. Liquidity
~3Y
Data Quality
Data: MediumLatent Health presents a strong upside opportunity driven by its specialized AI in a high-growth healthcare IT market with proven customer traction and a robust competitive moat.
Last updated: February 23, 2026
Latent Health achieves significant market penetration and expands its platform to new areas of hospital operations, leading to a successful acquisition or IPO at a premium valuation.
Latent Health continues to grow steadily, securing more health system customers and demonstrating strong product value, resulting in a moderate valuation increase.
Incumbent EHR vendors or well-funded AI competitors aggressively enter the prior authorization space, slowing Latent's growth and leading to a down round or less favorable exit.
Preference Stack Risk
highInvestors hold approximately $63.1M in liquidation preferences (total funding of $13.1M prior to Series B + $50M Series B) ahead of common shareholders, representing about 21% of the assumed current $300M post-money valuation. In an exit at or below this valuation, common stock may receive significantly less or nothing.
Dilution Risk
moderateAs a Series B company, Latent Health will likely require one or more additional funding rounds before a liquidity event, which will lead to further dilution of employee equity.
Secondary Liquidity
noneActive secondary markets or tender offers are typically not available for a Series B company of this size, limiting early liquidity options for employees.
Community
Valuation Sentiment
Our model estimates -41% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.